Sale!

WDR81 Gene Cerebellar Ataxia with Mental Retardation and Dysequilibrium Syndrome Type 2 Genetic Test

4,400 د.إ

-21%

The WDR81 gene cerebellar ataxia with mental retardation and dysequilibrium syndrome type 2 genetic test is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to identify mutations in the WDR81 gene, which are known to cause cerebellar ataxia with mental retardation and dysequilibrium syndrome type 2 (CAMRQ2). CAMRQ2 is a rare genetic disorder characterized by developmental delays, intellectual disability, and difficulties with coordination and balance due to cerebellar ataxia. The test is crucial for early diagnosis and management of the condition, offering insights that can guide therapeutic interventions and support. Priced at 4400 AED, the test involves analyzing the patient’s DNA to detect abnormalities in the WDR81 gene, providing families and healthcare professionals with essential information for care planning and genetic counseling.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

WDR81 Gene Cerebellar Ataxia with Mental Retardation and Dysequilibrium Syndrome Type 2 Genetic Test

Test Name: WDR81 Gene Cerebellar Ataxia with Mental Retardation and Dysequilibrium Syndrome Type 2 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for WDR81 Gene Cerebellar Ataxia with Mental Retardation and Dysequilibrium Syndrome Type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WDR81 Gene Cerebellar Ataxia with Mental Retardation and Dysequilibrium Syndrome Type 2.

Test Details

The WDR81 gene is associated with cerebellar ataxia with mental retardation and dysequilibrium syndrome type 2 (CAMRQ2), which is a rare genetic disorder that affects the nervous system. CAMRQ2 is characterized by a combination of symptoms including ataxia (uncoordinated movements), intellectual disability, and problems with balance and coordination (dysequilibrium). Other features of the condition may include seizures, delayed speech and language development, and abnormal eye movements.

NGS (next-generation sequencing) genetic testing can be used to identify mutations in the WDR81 gene that are associated with CAMRQ2. This type of testing can detect changes in the DNA sequence of the gene that may be responsible for causing the disorder. NGS testing can be performed using a small sample of blood or saliva, and results are typically available within a few weeks.

Genetic testing for CAMRQ2 can help to confirm a diagnosis, guide treatment decisions, and provide information about the risk of passing the condition on to future generations. It may also be useful for family members of affected individuals who may be at risk of inheriting the mutation. Genetic counseling is recommended for individuals who are considering genetic testing for CAMRQ2.

Test Name WDR81 Gene Cerebellar ataxia with mental retardation and dysequilibrium syndrome type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for WDR81 Gene Cerebellar ataxia with mental retardation and dysequilibrium syndrome type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with WDR81 Gene Cerebellar ataxia with mental retardation and dysequilibrium syndrome type 2
Test Details

The WDR81 gene is associated with cerebellar ataxia with mental retardation and dysequilibrium syndrome type 2 (CAMRQ2), which is a rare genetic disorder that affects the nervous system. CAMRQ2 is characterized by a combination of symptoms including ataxia (uncoordinated movements), intellectual disability, and problems with balance and coordination (dysequilibrium). Other features of the condition may include seizures, delayed speech and language development, and abnormal eye movements.

NGS (next-generation sequencing) genetic testing can be used to identify mutations in the WDR81 gene that are associated with CAMRQ2. This type of testing can detect changes in the DNA sequence of the gene that may be responsible for causing the disorder. NGS testing can be performed using a small sample of blood or saliva, and results are typically available within a few weeks.

Genetic testing for CAMRQ2 can help to confirm a diagnosis, guide treatment decisions, and provide information about the risk of passing the condition on to future generations. It may also be useful for family members of affected individuals who may be at risk of inheriting the mutation. Genetic counseling is recommended for individuals who are considering genetic testing for CAMRQ2.